Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-14 Sale | 2025-02-18 4:55 pm | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 1,159 | $3.15 | $3,651 | 192,505 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-28 Exercise | 2025-10-30 4:30 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Mahaney Paige Chief Scientific Officer | 19,200 | $0 | 99,356 (Direct) | View |
| 2025-10-28 Tax Withholding | 2025-10-30 4:30 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Mahaney Paige Chief Scientific Officer | 5,644 | $2.58 | 99,356 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:14 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director | 5,349 | $2.15 | 344,298 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:13 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director | 6,740 | $2.15 | 58,629 (Direct) | View |
| 2025-09-18 Tax Withholding | 2025-09-19 4:13 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 2,775 | $3.32 | 162,342 (Direct) | View |
| 2025-09-18 Exercise | 2025-09-19 4:13 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 6,250 | $0 | 162,342 (Direct) | View |
| 2025-07-10 Exercise(A) | 2025-07-15 09:00 am | N/A N/A | C4 Therapeutics Inc. | CCCC | REYNO LEONARD Chief Medical Officer | 15,325 | $0 | 166,382 (Direct) | View |
| 2025-07-10 Tax Withholding(A) | 2025-07-15 09:00 am | N/A N/A | C4 Therapeutics Inc. | CCCC | REYNO LEONARD Chief Medical Officer | 7,382 | $1.99 | 166,382 (Direct) | View |
| 2025-07-10 Tax Withholding | 2025-07-14 4:19 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | REYNO LEONARD Chief Medical Officer | 7,382 | $1.99 | 166,382 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-02 4:17 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director | 7,616 | $1.51 | 338,949 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-02 4:17 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director | 9,609 | $1.51 | 51,889 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 4:12 pm | N/A 2035-06-17 | C4 Therapeutics Inc. | CCCC | Koppikar Utpal Director | 35,500 | $0 | 35,500 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 4:11 pm | N/A 2035-06-17 | C4 Therapeutics Inc. | CCCC | Hughes Owen Director | 35,500 | $0 | 35,500 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 4:11 pm | N/A 2035-06-17 | C4 Therapeutics Inc. | CCCC | Fawell Stephen Director | 35,500 | $0 | 35,500 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 4:11 pm | N/A 2035-06-17 | C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director | 35,500 | $0 | 35,500 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 4:11 pm | N/A 2035-06-17 | C4 Therapeutics Inc. | CCCC | Bessen Laura Director | 35,500 | $0 | 35,500 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 4:11 pm | N/A 2035-06-17 | C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director | 35,500 | $0 | 35,500 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 4:10 pm | N/A 2035-06-17 | C4 Therapeutics Inc. | CCCC | Cooper Ronald Harold Wilfred Director | 35,500 | $0 | 35,500 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 4:10 pm | N/A 2035-06-17 | C4 Therapeutics Inc. | CCCC | Hoerter Steven L. Director | 35,500 | $0 | 35,500 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:11 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director | 9,581 | $1.435 | 42,280 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:11 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director | 7,841 | $1.435 | 331,333 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 4:55 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 22,217 | $3.18 | 758,445 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-18 4:55 pm | N/A 2035-02-13 | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 558,800 | $0 | 758,445 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 4:55 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 2,914 | $3.18 | 192,639 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-18 4:55 pm | N/A 2035-02-13 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 141,200 | $0 | 192,639 (Direct) | View |
| 2025-02-13 Tax Withholding | 2025-02-18 4:55 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 2,135 | $3.2 | 192,639 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 4:55 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 2,368 | $3.18 | 192,505 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-18 4:55 pm | N/A 2035-02-13 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 141,200 | $0 | 192,505 (Direct) | View |
| 2025-02-13 Tax Withholding | 2025-02-18 4:55 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 1,735 | $3.2 | 192,505 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 4:55 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Mossler Mark Chief Accounting Officer | 1,586 | $3.18 | 18,204 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 4:54 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer | 2,368 | $3.18 | 193,585 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-18 4:54 pm | N/A 2035-02-13 | C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer | 141,200 | $0 | 193,585 (Direct) | View |
| 2025-02-13 Tax Withholding | 2025-02-18 4:54 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer | 1,735 | $3.2 | 193,585 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 4:54 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 4,559 | $3.18 | 295,717 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-18 4:54 pm | N/A 2035-02-13 | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 217,700 | $0 | 295,717 (Direct) | View |
| 2025-02-13 Tax Withholding | 2025-02-18 4:54 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 1,863 | $3.2 | 295,717 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-18 4:54 pm | N/A 2035-02-13 | C4 Therapeutics Inc. | CCCC | Mahaney Paige Chief Scientific Officer | 70,600 | $0 | 147,400 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-18 4:54 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | REYNO LEONARD Chief Medical Officer | 5,145 | $3.18 | 304,364 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-18 4:54 pm | N/A 2035-02-13 | C4 Therapeutics Inc. | CCCC | REYNO LEONARD Chief Medical Officer | 217,700 | $0 | 304,364 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:08 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director | 3,757 | $3.66 | 32,699 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:08 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director | 3,074 | $3.66 | 323,492 (Direct) | View |
| 2024-11-19 Option Award | 2024-11-21 4:17 pm | N/A 2034-11-18 | C4 Therapeutics Inc. | CCCC | Hoerter Steven L. Director | 65,000 | $0 | 65,000 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-12 4:17 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 3,750 | $0 | 67,067 (Direct) | View |
| 2024-11-07 Tax Withholding | 2024-11-12 4:17 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Boyle Scott N Chief Business Officer | 1,102 | $6.04 | 67,067 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-12 4:17 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 3,750 | $0 | 94,939 (Direct) | View |
| 2024-11-07 Tax Withholding | 2024-11-12 4:17 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 1,102 | $6.04 | 94,939 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-12 4:17 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer | 3,750 | $0 | 66,988 (Direct) | View |
| 2024-11-07 Tax Withholding | 2024-11-12 4:17 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Schick Kelly Chief People Officer | 1,102 | $6.04 | 66,988 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-12 4:17 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 3,750 | $0 | 66,988 (Direct) | View |
| 2024-11-07 Tax Withholding | 2024-11-12 4:17 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Siegel Jolie Chief Legal Officer | 1,102 | $6.04 | 66,988 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-12 4:17 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 12,500 | $0 | 256,862 (Direct) | View |
| 2024-11-07 Tax Withholding | 2024-11-12 4:17 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Hirsch Andrew President & CEO | 5,550 | $6.04 | 256,862 (Direct) | View |
| 2024-10-28 Option Award | 2024-10-29 4:31 pm | N/A 2034-10-27 | C4 Therapeutics Inc. | CCCC | Mahaney Paige Chief Scientific Officer | 422,400 | $0 | 422,400 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-02 4:32 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | GROGAN DONNA ROY Director | 2,474 | $5.56 | 28,942 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-02 4:32 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Anderson Kenneth Carl Director | 2,023 | $5.56 | 320,418 (Direct) | View |
| 2024-09-18 Tax Withholding | 2024-09-20 4:13 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Adams Kendra Chief Financial Officer | 1,837 | $6.38 | 81,791 (Direct) | View |